Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Therapies Through Precision Behavioral Support: 79% of Members Already Using Dario's Weight Management [Accessibility Statement] Skip NavigationAs oral GLP-1s enter the market with slightly more modest weight and glycemic outcomes than injectable formulations, Dario integrates structured behavioral reinforcement to optimize real-world successGiven GLP-1 medication expense is one of the fastest-growing cost drivers for payers, Dario enables real-w ...

Lila Kate Trucking LLC, a Roanoke, Alabama-based carrier, filed for Chapter 11 bankruptcy protection on Friday. The company is seeking to reorganize under Subchapter V of Chapter 11, a provision designed to streamline restructuring for small businesses. The filing was made in the U.S. Bankruptcy Court for the Middle District of Alabama, according to court records. Assets and liabilities In its voluntary petition, Lila Kate Trucking estimated both its assets and liabilities at between $1 million and $10 ...

The company's approval to upgrade to the OTCQB Venture Market underscores a growing trend among international, growth-stage companies to expand U.S. investor access and enhance market liquidity. The OTCQB® Venture Market is designed for entrepreneurial and development-stage companies in the United States and abroad. ...

Vancouver, British Columbia--(Newsfile Corp. - March 3, 2026) - Atomic Minerals Corporation (TSXV: ATOM) (OTCQB: ATMMF) (FSE: DO8) ("Atomic Minerals" or the "Company") is pleased to announce the submission of drill permits at its 1,516.5 acre (614 hectare) South Lisbon Valley East property ("SLVE") located approximately 35 kilometres NE of Monticello, Utah. SLVE lies in the Colorado Plateau and covers the southern portion of a suspected belt of penecordant uranium mineralization hosted in the Moss Back memb ...

Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2026 MDA Clinical and Scientific Conference [Accessibility Statement] Skip NavigationBOULDER, Colo., March 3, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced its participation at the 2026 Muscular Dystrophy Association (MDA) Clinical and Scientific Conference. The Company will host a lunch forum with experts presenting Becke ...

Media Contact: YETI Holdings, Inc. Media Hotline Media@yeti.com Investor.relations@yeti.com AUSTIN, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- YETI Holdings, Inc. ("YETI") (NYSE: YETI) today announced that management will be attending the following investor conferences: Citi's 2026 Global Consumer & Retail Conference March 9, 2026 Miami, FL BofA Securities 2026 Consumer and Retail Conference March 10, 2026 Miami, FL About YETI Holdings, Inc. Headquartered in Austin, Texas, YETI is a global designer, retailer ...

tibial insert. The MS Insert is designed to provide enhanced stability5-7 for Triathlon primary knee patients, while allowing more natural rotational kinematics.8 "With more than 20 years of proven outcomes, the Triathlon system has set a high standard in knee replacement," said Lisa Kloes, vice president and general manager of Stryker's Knee business. "Triathlon Gold and the Triathlon Medial Stabilized (MS) Insert represent the next evolution of that legacy -- solutions shaped by customer insight and desig ...

-- On track to file IND and/or CTA for Wilson Disease and AATD programs in 1H 2026 and mid-2026, respectively; initial clinical data for both expected in 2027 -- -- Ongoing engagement with FDA for PM359 in CGD; plan to submit BLA following final alignment -- -- Prime Medicine reported cash, cash equivalents, investments, and restricted cash of $191M providing cash runway into 2027 -- CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed t ...

OAK BROOK, Ill., March 03, 2026 (GLOBE NEWSWIRE) -- Hub Group, Inc. (Nasdaq: HUBG) today announced that it has filed a Notification of Late Filing on Form 12b-25 with the U.S. Securities and Exchange Commission ("SEC") and will be delayed in filing its Annual Report on Form 10-K for the year ended December 31, 2025. The extension is required to allow additional time to finalize the Company's financial results for the fourth quarter and full year 2025. As previously announced, the Company plans to restate it ...

Presentation at THT 2026 Atrioventricular Interval Modulation Therapy: A Device-Based Therapy for Hypertension and Diastolic Heart Failure (Tuesday, March 3, 2026, at 10:20am ET) NEW HOPE, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) ("Orchestra BioMed" or the "Company"), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, today announced two presentations that wil ...